本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Artiva Biotherapeutics, Inc.

1.61
+0.02001.26%
盤後1.610.00000.00%15:29 EDT
成交量:7.82萬
成交額:12.63萬
市值:3,922.46萬
市盈率:-0.38
高:1.64
開:1.61
低:1.60
收:1.59
資料載入中...
2025/06/25

重要事件披露

Form 8-K - Current report
2025/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/08

重要事件披露

Form 8-K - Current report
2025/03/24

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/24

重要事件披露

Form 8-K - Current report
2025/01/29

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/10/22

重要事件披露

Form 8-K - Current report
2024/09/03

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/29

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/29

重要事件披露

Form 8-K - Current report
2024/08/01

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/08/01

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/08/01

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/07/29

超過5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/07/29

超過5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/07/22

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/07/22

重要事件披露

Form 8-K - Current report